Case Report: Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage IIIA-N2 ALK-Positive Non-Small-Cell Lung Cancer

by Xiao-Hong Xie, Xiao-Hong Xie, Ze-Jiang Zhan, Ze-Jiang Zhan, Yin-Yin Qin, Yin-Yin Qin, Ju-Hong Jiang, Ju-Hong Jiang, Wei-Qiang Yin, Wei-Qiang Yin, Rong-Hui Zheng, Rong-Hui Zheng, Shi-Yue Li, Shi-Yue Li, Cheng-Zhi Zhou, Cheng-Zhi Zhou
Published 2021-03-01

CHRNA3 Polymorphism Modifies Lung Adenocarcinoma Risk in the Chinese Han Population

by Ping He, Xue-Xi Yang, Xuan-Qiu He, Jun Chen, Fen-Xia Li, Xia Gu, Ju-Hong Jiang, Hui-Ying Liang, Guang-Yu Yao, Jian-Xing He
Published 2014-03-01